Peroxisome Proliferator Activated Receptor α Ligands as Anticancer Drugs Targeting Mitochondrial Metabolism

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|14|3|342-356

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.14, Iss.3, 2013-03, pp. : 342-356

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome proliferator-activated receptor ligands in atherosclerosis

By Viles-Gonzalez Juan F   Choi Brian G   Fuster Valentin   Badimon Juan J  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1393-1403

Informa Healthcare

Access to resources Recommend Favorite

Synthetic ligands for peroxisome proliferator-activated receptor-α, review of the patent literature 2000 – 2003

By Miyachi Hiroyuki  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 5, 2004-05 ,pp. : 607-618

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor-γ ligands as investigational modulators of angiogenesis

By Giaginis Costas   Margeli Alexandra   Theocharis Stamatios  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1561-1572

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor-γ ligands for the treatment of breast cancer

By Fenner Martin H   Elstner Elena  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 557-568

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor-β as a target for wound healing drugs

By Tan Nguan Soon   Michalik Liliane   Desvergne Béatrice   Wahli Walter  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 1, 2004-02 ,pp. : 39-48

Informa Healthcare

Access to resources Recommend Favorite